AI-generated summary
The authors tested a new light and magnetic device, RGn500, in mice given amyloid beta 25-35 peptide to model Alzheimer's disease. Daily 10-minute applications to the head and abdomen for 7 days were associated with memory restoration and normalization of several disease markers. The study was in mice, so results may not apply to people.
- Who or what was studied
- Male Swiss mice with amyloid beta 25-35 peptide injection as an Alzheimer's disease model
- Limits stated in the abstract
- The study was conducted in a mouse model, and the abstract does not report sample size or a control group.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on alz-journals.onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Neuroinflammation, Oxidative stress. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.